Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents: Combination of Pharmacogenomics and Therapeutic Drug Monitoring

NCT00545467 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT00545467
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00545467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents: Combination of Pharmacogenomics and Therapeutic Drug Monitoring
Lead sponsor
National Taiwan University Hospital
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2007
Completion date
July 31, 2009
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dsm-iv schizophrenia, schizoaffective disorder